Published in J Virol on August 01, 1999
The role of CD4 T cells in the pathogenesis of murine AIDS. J Virol (2006) 0.98
Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency. J Virol (2001) 0.93
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation. Arthritis Res (1999) 0.87
Interleukin-4 up-regulates mouse mammary tumor virus expression yet is not required for in vivo virus spread. J Virol (2001) 0.78
Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity (1996) 8.16
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature (1996) 6.17
An interleukin-4-induced transcription factor: IL-4 Stat. Science (1994) 4.71
The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell (1989) 4.48
Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A (1996) 2.57
Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol (1989) 2.41
Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS (1992) 1.97
Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB J (1991) 1.82
Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J Virol (1991) 1.70
CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol (1992) 1.62
Characteristics of B cell proliferation and activation in murine AIDS. J Immunol (1989) 1.61
IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J Immunol (1996) 1.19
Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse. J Exp Med (1996) 1.13
Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J Biol Chem (1995) 1.09
Murine AIDS is an antigen-driven disease: requirements for major histocompatibility complex class II expression and CD4+ T cells. J Virol (1994) 1.09
Resistance to murine acquired immunodeficiency syndrome (MAIDS) Science (1994) 1.07
The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression. J Immunol (1997) 1.06
An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus. Int Immunol (1994) 1.03
A unique subset of normal murine CD4+ T cells lacking Thy-1 is expanded in a murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur J Immunol (1990) 1.01
Relationship of cytokines and cytokine signaling to immunodeficiency disorders in the mouse. Braz J Med Biol Res (1998) 0.84
Plasma cell differentiation requires the transcription factor XBP-1. Nature (2001) 9.72
Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity (1996) 8.16
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature (1996) 6.23
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell (1993) 5.99
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14
Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science (1997) 3.92
The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity (1999) 3.61
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol (1998) 3.48
Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol (1999) 3.21
Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity (1996) 3.05
CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science (1999) 2.60
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 2.58
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med (1999) 2.42
The biology of Stat4 and Stat6. Oncogene (2000) 2.40
Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity (1994) 2.40
Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med (1998) 2.28
Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol (1998) 2.20
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest (2001) 2.19
PDGF-D, a new protease-activated growth factor. Nat Cell Biol (2001) 2.17
The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity (1998) 2.13
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol (2001) 2.03
Psychiatric evaluation of a "monk" requesting castration: a patient's fable, with morals. Am J Psychiatry (1998) 2.01
Burkitt lymphoma in the mouse. J Exp Med (2000) 1.96
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.86
Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature (1996) 1.82
Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity (1999) 1.69
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest (2000) 1.65
Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice. Leuk Res (2001) 1.64
Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.61
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med (1994) 1.61
Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc Natl Acad Sci U S A (1999) 1.60
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res (2000) 1.55
Should competent patients or their families be able to refuse to allow an HEC case review? Yes. HEC Forum (1995) 1.47
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol (2001) 1.44
Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol (1996) 1.43
Uncertainty and opposition of medical students toward assisted death practices. J Pain Symptom Manage (2001) 1.43
Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J Exp Med (1993) 1.40
The wounds of the bull. Pharos Alpha Omega Alpha Honor Med Soc (1991) 1.39
A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J Exp Med (1998) 1.36
Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol (1999) 1.34
Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways. J Immunol (2000) 1.33
Two levels of help for B cell alloantibody production. J Exp Med (1996) 1.31
Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J Exp Med (1999) 1.31
Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF alpha-receptors. Development (1996) 1.30
Regulation of T helper cell differentiation by STAT molecules. J Leukoc Biol (1998) 1.30
STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J Immunol (1998) 1.27
Pathogenesis of experimental allergic orchitis. III. T lymphocyte requirement in local adoptive transfer by peritoneal exudate cells. J Immunol (1977) 1.27
Peripheral lymphoid development and function in TCR mutant mice. Int Immunol (1994) 1.26
B lymphocyte development and activation independent of MHC class II expression. J Immunol (1993) 1.25
Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med (1994) 1.24
Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J Immunol (2000) 1.22
Positive selection of CD4+ T cells by TCR ligation without aggregation even in the absence of MHC. Nature (1994) 1.21
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut (2005) 1.20
The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest (2000) 1.19
Decreased neonatal dietary fat absorption and T cell cytotoxicity in pancreatic lipase-related protein 2-deficient mice. J Biol Chem (1998) 1.17
Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma. J Immunol (2000) 1.16
Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol (1998) 1.15
Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. Cancer Biol Ther (2005) 1.14
Stat6-dependent and -independent pathways for IL-4 production. J Immunol (1999) 1.14
In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J Exp Med (1994) 1.14
IL-12, STAT4-dependent up-regulation of CD4(+) T cell core 2 beta-1,6-n-acetylglucosaminyltransferase, an enzyme essential for biosynthesis of P-selectin ligands. J Immunol (2001) 1.13
The role of individual cysteine residues in the structure and function of the v-sis gene product. Science (1987) 1.12
Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. J Exp Med (1993) 1.11
A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice. Cell Immunol (1999) 1.10
Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell (1994) 1.10
Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J Immunol (1999) 1.09
Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses. Lab Invest (2000) 1.08
Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. Br J Cancer (2008) 1.07
Resistance to murine acquired immunodeficiency syndrome (MAIDS) Science (1994) 1.07
In vitro mutagenesis of the v-sis transforming gene defines functional domains of its growth factor-related product. Proc Natl Acad Sci U S A (1985) 1.07
Antigen-presenting function of B lymphocytes. Immunol Rev (1988) 1.06
Thymocyte development in major histocompatibility complex-deficient mice: evidence for stochastic commitment to the CD4 and CD8 lineages. Proc Natl Acad Sci U S A (1993) 1.02
Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J Exp Med (2001) 1.02
Most gamma delta T cells develop normally in the absence of MHC class II molecules. J Immunol (1993) 1.01
ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer. J Cell Mol Med (2007) 1.01
Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. Mol Cell Biol (2001) 0.98
Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol (2000) 0.97
Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation. Proc Natl Acad Sci U S A (1984) 0.96
Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J Infect Dis (1995) 0.96
Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections. Clin Exp Immunol (2008) 0.95
Activation of T cells by superantigen in class II-negative mice. J Immunol (1994) 0.95
Perceptions of the ethical acceptability of using medical examiner autopsies for research and education: a survey of forensic pathologists. Arch Pathol Lab Med (2000) 0.93
Core-binding factor influences the disease specificity of Moloney murine leukemia virus. J Virol (1999) 0.93
Genomic organisation and expression of BCL6 in murine B-cell lymphomas. Leuk Res (2000) 0.92
Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc Natl Acad Sci U S A (1997) 0.92
Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy. Int J Cancer (2013) 0.91
Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer. Cancer Immunol Immunother (2010) 0.91
Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts. Oncogene (1999) 0.91
Transgenic mice expressing MHC class II molecules with truncated A beta cytoplasmic domains reveal signaling-independent defects in antigen presentation. Int Immunol (1995) 0.90
Functional importance of platelet-derived growth factor (PDGF) receptor extracellular immunoglobulin-like domains. Identification of PDGF binding site and neutralizing monoclonal antibodies. J Biol Chem (1997) 0.90
Renal infection due to adenovirus in a patient with human immunodeficiency virus infection. Clin Infect Dis (1994) 0.90
The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis. J Clin Pathol (2006) 0.89
Immunoregulatory effects of superantigens: interactions of staphylococcal enterotoxins with host MHC and non-MHC products. Immunol Rev (1993) 0.89
STATs as mediators of cytokine-induced responses. Adv Immunol (1999) 0.88
Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin. J Virol (1997) 0.87
Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy. J Reprod Immunol (1997) 0.86
Effects of exogenous, nonleukemogenic, ecotropic murine leukemia virus infections on the immune systems of adult C57BL/6 mice. J Virol (1995) 0.85
What and how psychiatry residents at ten training programs wish to learn about ethics. Acad Psychiatry (1996) 0.85